Nutrilipid Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
How Supplied
Emulsion (250mL, 500mL)—1
Manufacturer
Generic Availability
Mechanism of Action
Nutrilipid Indications
Indications
Nutrilipid Dosage and Administration
Adults and Children
Nutrilipid Contraindications
Contraindications
Egg, soybean, or peanut allergy. Severe disorders of lipid metabolism characterized by hypertriglyceridemia (serum triglyceride >1000mg/dL).
Nutrilipid Boxed Warnings
Not Applicable
Nutrilipid Warnings/Precautions
Warnings/Precautions
Clinical decompensation with rapid IV infusion in neonates/infants. Risk of parenteral nutrition-associated liver disease (eg, cholestasis or hepatic steatosis), other hepatobiliary disorders (eg, cholecystitis and cholelithiasis); monitor liver function and consider discontinuation or dose reduction if abnormalities occur. Correct severe fluid and electrolyte disorders, fluid overload states, and metabolic disorders prior to initiating. Measure serum triglycerides at baseline, with each dose increase, and regularly during therapy. Monitor overall energy intake, other sources of fat and glucose, drugs that may interfere with lipid and glucose metabolism. Discontinue and treat if hypersensitivity reactions occur. Monitor for signs/symptoms of infection and essential fatty acid deficiency (EFAD). Severely undernourished: avoid overfeeding. Pulmonary edema or heart failure: monitor fluid status closely. Monitor fluids, electrolytes, serum osmolarity, blood glucose, liver and kidney function, CBCs, platelets, coagulation parameters throughout treatment. Hepatic impairment. Elderly. Neonates: risk of thrombocytopenia; monitor platelets frequently. Pregnancy. Nursing mothers.
Nutrilipid Pharmacokinetics
See Literature
Nutrilipid Interactions
Interactions
Nutrilipid Adverse Reactions
Adverse Reactions
Nutrilipid Clinical Trials
See Literature
Nutrilipid Note
Not Applicable
Nutrilipid Patient Counseling
See Literature